VAXONELLA

Welcome to the Brand page for “VAXONELLA”, which is offered here for [ pharmaceutical preparations for treating e. coli infection, c. difficile infection, chlamydia infection, salmonella infection, shigella infection, campylobacter infection, mycobacterium tuberculosis infection, hiv infection, influenza infection, yersinia pestis infection, bacillus anthracis infection; veterinary preparations, vaccines; prophylactic preparations, prophylactic vaccines; therapeutic pharmaceuticals for the treatment of e. coli infection, c. difficile infection, chlamydia infection, salmonella infection, shigella infection, campylobacter infection, mycobacterium tuberculosis infection, hiv infection, influenza infection, yersinia pestis infection, bacillus anthracis infection; vaccines ];medical testing services for diagnostic and treatment services in the field of prophylactic preparations and therapeutic pharmaceuticals; medical services;scientific research services; biologics development services, prophylactic vaccine development services; medical research;.

Its status is currently believed to be active. Its class is unavailable. “VAXONELLA” is believed to be currently owned by “Prokarium Limited”.